CellChorus
YC S21Houston, US · Founded 2020 · 4 employees · 5 known investors
Find your way into CellChorus
Sign up to see every warm intro you have to CellChorus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CellChorus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research. The company serves biopharmaceutical companies and therapy developers seeking to understand cellular function and phenotype.
Founders & leadership· Y Combinator alumni (S21)
CellChorus was founded in 2020 by Dan Meyer, Navin Varadarajan, and Laurence Cooper.


Investors · 5
How we know: Breakout Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSmall Business Innovation Research (SBIR) grantJul 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 6
Companies working in the same space as CellChorus.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $324.3K |
| National Science Foundation | Phase I | 2023 | $275K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Legal entities · 1
corporate structureIn the news
Frequently asked questions
- What does CellChorus do?
- CellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research. The company serves biopharmaceutical companies and therapy developers seeking to understand cellular function and phenotype.
- Who founded CellChorus?
- CellChorus was founded by Dan Meyer, Navin Varadarajan, Laurence Cooper in 2020.
- Who are CellChorus's investors?
- CellChorus's investors include Breakout Ventures, Houston Angel Network, Texas HALO Fund, Y Combinator, Asymmetry Ventures.
- Where is CellChorus headquartered?
- CellChorus is headquartered in Houston, US.












